Dow Jones Top Company Headlines at 1 PM ET: How Meta's Newest Acquisition Target Got Around Worries Over Its Ties to China | OpenAI ... How Meta's Newest Acquisition Target Got Around Worries Over Its ...

Dow Jones Top Company Headlines at 5 PM ET: Saks Prepares for Bankruptcy After Missing Debt Payment | How ... The owner of Saks Fifth Avenue and Neiman Marcus is in talks with creditors about ...

As of Wednesday, December 31, Vanda Pharmaceuticals Inc.’s VNDA share price has surged by 34.23%, which has investors ...

Vanda Pharmaceuticals said on Tuesday its drug for the prevention of motion-induced vomiting was approved by the U.S. health ...

Vanda Pharmaceuticals (VNDA) stock rises as the FDA approves its motion sickness therapy Nereus, developed in partnership ...

H.C. Wainwright raised the firm’s price target on Vanda Pharmaceuticals (VNDA) to $22 from $20 and keeps a Buy rating on the shares. The firm ...

(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA), Monday announced that the company has submitted a Biologics License Application or BLA to the U.S. Food and Drug Administration for imsidolimab to treat ...

WASHINGTON, Dec. 11, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the J.P. Morgan Healthcare Conference in San Francisco, ...

B. Riley raised the firm’s price target on Vanda Pharmaceuticals (VNDA) to $14 from $11 and keeps a Buy rating on the shares after the FDA ...

The pharmaceutical giant Eli Lilly enters the new year facing a dual narrative of innovation and market pressure. Recent regulatory approval for a partnered drug contrasts with significant mandated ...

Amid rapidly evolving media consumption habits and a federal push to limit direct-to-consumer drug advertising, pharma companies in 2026 and beyond are on track to continue their migration away from ...

GSK (GSK) and other leading drugmakers plans to raise prices of as many as 350 medicines next year, with a median hike of ...